Format

Send to

Choose Destination
Eur Respir J. 2014 Jul;44(1):239-41. doi: 10.1183/09031936.00220413. Epub 2014 Mar 23.

The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophilia.

Author information

1
GlaxoSmithKline, Respiratory Medicine Development Center, Research Triangle Park, NC, USA hector.g.ortega@gsk.com.
2
Dept of Pulmonary and Critical Care, Yale University Medical School, Winchester Chest Clinic, 20 York Street, New Haven, CT, USA.
3
Monash University and Medical Centre, Lung and Sleep, Melbourne, Australia.
4
Dept of Allergy, Hospital Arnaud de Villeneuve, Montpellier, France.
5
University Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
6
GlaxoSmithKline, Research and Development, Stockley Park, Middlesex, UK.
7
GlaxoSmithKline, Respiratory Medicine Development Center, Research Triangle Park, NC, USA.
8
University Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France Inserm U999, LabEx LERMIT, Le Plessis Robinson, France.
PMID:
24659543
DOI:
10.1183/09031936.00220413
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center